US Pharmaceutical Manufacturer Achieves Zero Contamination with KAIEN LGV-540 Oil Free Vacuum Pump

A mid-sized pharmaceutical manufacturer based in New Jersey, United States, specializing in sterile injectable drugs and lyophilized products, faced a persistent contamination challenge in their freeze-drying vacuum system. The facility's legacy oil-sealed rotary vane pumps, despite regular maintenance, were generating trace oil mist backstreaming that periodically compromised the sterility of lyophilized vials during the critical primary drying phase. With annual production valued at over $80 million and FDA audit requirements becoming increasingly stringent, the company initiated a search for an oil-free vacuum solution that could meet both their technical specifications and budget constraints.

The pharmaceutical manufacturer's lyophilization suite operated three freeze dryers simultaneously, each requiring vacuum levels of ≤10 Pa during the sublimation phase. The existing oil-sealed pumps demanded monthly oil changes, quarterly seal replacements, and annual major overhauls that collectively consumed over 120 hours of maintenance technician time per year. More critically, the facility experienced an average of 3-4 batch rejections per year attributed to oil-related contamination, each representing approximately $45,000 in lost product and documentation costs. The engineering team required a solution that would eliminate oil from the vacuum process entirely while maintaining or exceeding the pumping performance of the existing system.

After evaluating proposals from three international vacuum pump manufacturers, the company selected two KAIEN LGV-540 Oil Free Dry Screw Vacuum Pumps with air-cooled configuration. The selection criteria prioritized the following key features:

• Oil-Free Dry Operation: Zero lubrication in the working chamber eliminated any possibility of hydrocarbon contamination reaching the product, a critical requirement validated during FDA pre-approval inspection review.
• High Vacuum Performance: The LGV-540 delivers ≤5 Pa ultimate pressure with 540 m³/h pumping speed, exceeding the lyophilization system's 10 Pa requirement with substantial safety margin for future capacity expansion.
• Air-Cooled Design: Eliminated the need for process cooling water connections, simplifying installation and avoiding the facility's ongoing challenge with cooling water quality management.
• Compact Footprint: The 1,578 x 543 x 860 mm dimensions matched the existing pump alcove space without requiring structural modification, saving an estimated $12,000 in facility adaptation costs.

Installation and commissioning of both LGV-540 units was completed within five working days by the manufacturer's in-house maintenance team, supported by remote technical guidance from KAIEN's engineering department. The pumps were integrated with the existing lyophilizer control systems via Modbus RTU communication, enabling centralized monitoring of vacuum levels, pump temperature, and operating hours from the facility's SCADA platform.

Twelve months after installation, the pharmaceutical manufacturer reported complete elimination of oil-related batch rejections, a 32% reduction in vacuum system energy consumption, and an 85% decrease in maintenance labor hours. The company's quality assurance director noted that the KAIEN pumps had passed three consecutive FDA surveillance audits without a single observation related to vacuum system contamination, a first in the facility's 15-year operating history. Based on these results, the manufacturer has placed an order for two additional LGV-540 units for a planned lyophilization capacity expansion in 2027.

The total project cost, including equipment, shipping, installation, and first-year spare parts, was recovered within 14 months through combined savings in maintenance labor, energy consumption, and eliminated product losses. The engineering team has since standardized on KAIEN oil free vacuum pumps for all new clean room vacuum applications across the company's three US manufacturing sites.